LINDSEY FREHNER: Open Payments
NPI 1598001133 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$380 in 16 payments from 10 companies in 2025. Trend: 2023 $207 · 2024 $163 · 2025 $380
Food & beverage: $380
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $84 |
| ViiV Healthcare Company | 2 | $69 |
| MILLICENT US INC | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Biogen, Inc. | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Becton, Dickinson and Company | 1 | $19 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $17 |
| Exeltis, USA Inc. | 1 | $15 |
| Evofem Biosciences, Inc. | 1 | $15 |
Products named: Veozah, APRETUDE, FEMLYV, Lynkuet, Mirena, ZURZUVAE, FETAL FIBRONECTIN ENZYME IMMUNOASSAY, INTRAROSA.
Industry payments across CA — which companies pay providers there.
